CLINICAL_TRIALS
trial_result
· 2019-06-19
Clinical Trial Update: Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study [Phase 1, Phase 2]
Summary
A phase 1/2 trial investigating switching to ticagrelor for patients with Critical Limb Ischemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Southern California | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-19